nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Costochondritis—Varenicline—nicotine dependence	0.0375	0.0566	CcSEcCtD
Gabapentin—Snoring—Varenicline—nicotine dependence	0.0271	0.0409	CcSEcCtD
Gabapentin—Somnambulism—Varenicline—nicotine dependence	0.0196	0.0296	CcSEcCtD
Gabapentin—CACNA1B—midbrain—nicotine dependence	0.0192	0.153	CbGeAlD
Gabapentin—BCAT1—midbrain—nicotine dependence	0.0151	0.12	CbGeAlD
Gabapentin—CACNA2D2—midbrain—nicotine dependence	0.0139	0.11	CbGeAlD
Gabapentin—Abnormal faeces—Varenicline—nicotine dependence	0.0138	0.0208	CcSEcCtD
Gabapentin—Joint stiffness—Varenicline—nicotine dependence	0.013	0.0197	CcSEcCtD
Gabapentin—CACNA2D1—cardiovascular system—nicotine dependence	0.0128	0.102	CbGeAlD
Gabapentin—Facial paralysis—Varenicline—nicotine dependence	0.0124	0.0187	CcSEcCtD
Gabapentin—ADORA1—cardiovascular system—nicotine dependence	0.0123	0.0981	CbGeAlD
Gabapentin—CACNA1B—brain—nicotine dependence	0.0121	0.0962	CbGeAlD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0113	0.0532	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0107	0.0505	CbGpPWpGaD
Gabapentin—Varicose vein—Varenicline—nicotine dependence	0.0106	0.0159	CcSEcCtD
Gabapentin—Haematochezia—Varenicline—nicotine dependence	0.00976	0.0147	CcSEcCtD
Gabapentin—ADORA1—midbrain—nicotine dependence	0.00961	0.0766	CbGeAlD
Gabapentin—VIIth nerve paralysis—Varenicline—nicotine dependence	0.00958	0.0145	CcSEcCtD
Gabapentin—BCAT1—brain—nicotine dependence	0.00949	0.0757	CbGeAlD
Gabapentin—Hoarseness—Varenicline—nicotine dependence	0.00894	0.0135	CcSEcCtD
Gabapentin—CACNA2D2—brain—nicotine dependence	0.00871	0.0694	CbGeAlD
Gabapentin—CACNA1B—Neuronal System—CHRNB3—nicotine dependence	0.00866	0.0408	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—CHRNA6—nicotine dependence	0.00821	0.0387	CbGpPWpGaD
Gabapentin—Peripheral vascular disorder—Varenicline—nicotine dependence	0.00802	0.0121	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00774	0.0365	CbGpPWpGaD
Gabapentin—Suicide—Varenicline—nicotine dependence	0.00758	0.0114	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00748	0.0353	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00742	0.035	CbGpPWpGaD
Gabapentin—Balance disorder—Varenicline—nicotine dependence	0.00719	0.0109	CcSEcCtD
Gabapentin—Hostility—Varenicline—nicotine dependence	0.0071	0.0107	CcSEcCtD
Gabapentin—Urine abnormality—Varenicline—nicotine dependence	0.0071	0.0107	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0071	0.0334	CbGpPWpGaD
Gabapentin—Osteoporosis—Varenicline—nicotine dependence	0.00701	0.0106	CcSEcCtD
Gabapentin—Sexual dysfunction—Varenicline—nicotine dependence	0.00701	0.0106	CcSEcCtD
Gabapentin—Suicide attempt—Varenicline—nicotine dependence	0.00693	0.0105	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.0069	0.0325	CbGpPWpGaD
Gabapentin—Urine analysis abnormal—Varenicline—nicotine dependence	0.00669	0.0101	CcSEcCtD
Gabapentin—Completed suicide—Varenicline—nicotine dependence	0.00669	0.0101	CcSEcCtD
Gabapentin—Vaginal discharge—Varenicline—nicotine dependence	0.00646	0.00976	CcSEcCtD
Gabapentin—Libido increased—Varenicline—nicotine dependence	0.00646	0.00976	CcSEcCtD
Gabapentin—CACNA2D1—brain—nicotine dependence	0.00626	0.0499	CbGeAlD
Gabapentin—Psoriasis—Varenicline—nicotine dependence	0.00625	0.00944	CcSEcCtD
Gabapentin—ADORA1—brain—nicotine dependence	0.00604	0.0482	CbGeAlD
Gabapentin—CACNA1B—Neuronal System—GABRA4—nicotine dependence	0.00593	0.028	CbGpPWpGaD
Gabapentin—Menstrual disorder—Varenicline—nicotine dependence	0.00577	0.00871	CcSEcCtD
Gabapentin—Paranoia—Varenicline—nicotine dependence	0.00577	0.00871	CcSEcCtD
Gabapentin—Intestinal obstruction—Varenicline—nicotine dependence	0.00577	0.00871	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—CHRNB3—nicotine dependence	0.00573	0.027	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—CHRNB4—nicotine dependence	0.00569	0.0268	CbGpPWpGaD
Gabapentin—Haematemesis—Varenicline—nicotine dependence	0.00566	0.00854	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00563	0.0265	CbGpPWpGaD
Gabapentin—Delusion—Varenicline—nicotine dependence	0.00555	0.00839	CcSEcCtD
Gabapentin—Nystagmus—Varenicline—nicotine dependence	0.0055	0.00831	CcSEcCtD
Gabapentin—Hyperlipidaemia—Varenicline—nicotine dependence	0.00545	0.00823	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—CHRNA6—nicotine dependence	0.00544	0.0256	CbGpPWpGaD
Gabapentin—Mania—Varenicline—nicotine dependence	0.00541	0.00816	CcSEcCtD
Gabapentin—Menorrhagia—Varenicline—nicotine dependence	0.00531	0.00802	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—CHRNA5—nicotine dependence	0.00529	0.0249	CbGpPWpGaD
Gabapentin—Scotoma—Varenicline—nicotine dependence	0.00518	0.00782	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00513	0.0242	CbGpPWpGaD
Gabapentin—Gingivitis—Varenicline—nicotine dependence	0.00501	0.00756	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00497	0.0234	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00495	0.0233	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00492	0.0232	CbGpPWpGaD
Gabapentin—Nephrolithiasis—Varenicline—nicotine dependence	0.00489	0.00738	CcSEcCtD
Gabapentin—Glycosuria—Varenicline—nicotine dependence	0.00485	0.00733	CcSEcCtD
Gabapentin—Dysphonia—Varenicline—nicotine dependence	0.00478	0.00721	CcSEcCtD
Gabapentin—Acne—Varenicline—nicotine dependence	0.00467	0.00705	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00457	0.0215	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.0045	0.0212	CbGpPWpGaD
Gabapentin—Accidental injury—Varenicline—nicotine dependence	0.00444	0.00671	CcSEcCtD
Gabapentin—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00435	0.00657	CcSEcCtD
Gabapentin—Viral infection—Varenicline—nicotine dependence	0.00435	0.00657	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—CHRNA3—nicotine dependence	0.00431	0.0203	CbGpPWpGaD
Gabapentin—Thinking abnormal—Varenicline—nicotine dependence	0.00429	0.00648	CcSEcCtD
Gabapentin—Lacrimation increased—Varenicline—nicotine dependence	0.00427	0.00644	CcSEcCtD
Gabapentin—Nocturia—Varenicline—nicotine dependence	0.00424	0.0064	CcSEcCtD
Gabapentin—Dysarthria—Varenicline—nicotine dependence	0.00416	0.00628	CcSEcCtD
Gabapentin—Coordination abnormal—Varenicline—nicotine dependence	0.004	0.00604	CcSEcCtD
Gabapentin—Pulmonary embolism—Varenicline—nicotine dependence	0.00393	0.00594	CcSEcCtD
Gabapentin—Blood pressure increased—Varenicline—nicotine dependence	0.00393	0.00594	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—GABRA4—nicotine dependence	0.00393	0.0185	CbGpPWpGaD
Gabapentin—Abnormal dreams—Varenicline—nicotine dependence	0.00388	0.00587	CcSEcCtD
Gabapentin—Eructation—Varenicline—nicotine dependence	0.00386	0.00583	CcSEcCtD
Gabapentin—Salivary hypersecretion—Varenicline—nicotine dependence	0.00382	0.00576	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—CHRNB2—nicotine dependence	0.0038	0.0179	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CHRNB4—nicotine dependence	0.00377	0.0178	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00373	0.0176	CbGpPWpGaD
Gabapentin—Photophobia—Varenicline—nicotine dependence	0.00369	0.00557	CcSEcCtD
Gabapentin—Dry eye—Varenicline—nicotine dependence	0.00363	0.00548	CcSEcCtD
Gabapentin—Oesophagitis—Varenicline—nicotine dependence	0.00359	0.00542	CcSEcCtD
Gabapentin—Urine output increased—Varenicline—nicotine dependence	0.00355	0.00537	CcSEcCtD
Gabapentin—Mouth ulceration—Varenicline—nicotine dependence	0.00355	0.00537	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—CHRNA5—nicotine dependence	0.0035	0.0165	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—CHRNA4—nicotine dependence	0.00345	0.0162	CbGpPWpGaD
Gabapentin—Hypertonia—Varenicline—nicotine dependence	0.00345	0.0052	CcSEcCtD
Gabapentin—Mental disability—Varenicline—nicotine dependence	0.00341	0.00515	CcSEcCtD
Gabapentin—Euphoric mood—Varenicline—nicotine dependence	0.00338	0.0051	CcSEcCtD
Gabapentin—Lymphadenopathy—Varenicline—nicotine dependence	0.00334	0.00505	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00328	0.0155	CbGpPWpGaD
Gabapentin—Diabetes mellitus—Varenicline—nicotine dependence	0.00328	0.00495	CcSEcCtD
Gabapentin—Polyuria—Varenicline—nicotine dependence	0.00325	0.00491	CcSEcCtD
Gabapentin—Disorientation—Varenicline—nicotine dependence	0.00319	0.00482	CcSEcCtD
Gabapentin—Deafness—Varenicline—nicotine dependence	0.00319	0.00482	CcSEcCtD
Gabapentin—Eczema—Varenicline—nicotine dependence	0.00318	0.00479	CcSEcCtD
Gabapentin—Eye pain—Varenicline—nicotine dependence	0.00316	0.00477	CcSEcCtD
Gabapentin—Injury—Varenicline—nicotine dependence	0.0031	0.00469	CcSEcCtD
Gabapentin—Renal failure acute—Varenicline—nicotine dependence	0.00309	0.00467	CcSEcCtD
Gabapentin—Libido decreased—Varenicline—nicotine dependence	0.00308	0.00465	CcSEcCtD
Gabapentin—Increased appetite—Varenicline—nicotine dependence	0.00304	0.00459	CcSEcCtD
Gabapentin—Amnesia—Varenicline—nicotine dependence	0.00304	0.00459	CcSEcCtD
Gabapentin—Atrial fibrillation—Varenicline—nicotine dependence	0.00301	0.00455	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00301	0.0142	CbGpPWpGaD
Gabapentin—Thirst—Varenicline—nicotine dependence	0.003	0.00453	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00298	0.014	CbGpPWpGaD
Gabapentin—Arthritis—Varenicline—nicotine dependence	0.00294	0.00443	CcSEcCtD
Gabapentin—Hypoglycaemia—Varenicline—nicotine dependence	0.00292	0.00441	CcSEcCtD
Gabapentin—Cerebrovascular accident—Varenicline—nicotine dependence	0.00291	0.0044	CcSEcCtD
Gabapentin—Lethargy—Varenicline—nicotine dependence	0.00291	0.0044	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—CHRNA3—nicotine dependence	0.00286	0.0135	CbGpPWpGaD
Gabapentin—Osteoarthritis—Varenicline—nicotine dependence	0.00285	0.00431	CcSEcCtD
Gabapentin—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00283	0.00427	CcSEcCtD
Gabapentin—Migraine—Varenicline—nicotine dependence	0.00281	0.00424	CcSEcCtD
Gabapentin—Affect lability—Varenicline—nicotine dependence	0.00281	0.00424	CcSEcCtD
Gabapentin—Psychotic disorder—Varenicline—nicotine dependence	0.00279	0.00421	CcSEcCtD
Gabapentin—Irritability—Varenicline—nicotine dependence	0.00272	0.00411	CcSEcCtD
Gabapentin—Urinary retention—Varenicline—nicotine dependence	0.00271	0.0041	CcSEcCtD
Gabapentin—Mood swings—Varenicline—nicotine dependence	0.0027	0.00408	CcSEcCtD
Gabapentin—Liver function test abnormal—Varenicline—nicotine dependence	0.00263	0.00398	CcSEcCtD
Gabapentin—Dry skin—Varenicline—nicotine dependence	0.00262	0.00395	CcSEcCtD
Gabapentin—Breast disorder—Varenicline—nicotine dependence	0.00258	0.00389	CcSEcCtD
Gabapentin—Nasopharyngitis—Varenicline—nicotine dependence	0.00255	0.00385	CcSEcCtD
Gabapentin—Gastritis—Varenicline—nicotine dependence	0.00253	0.00381	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—CHRNB2—nicotine dependence	0.00251	0.0118	CbGpPWpGaD
Gabapentin—Dysphagia—Varenicline—nicotine dependence	0.00247	0.00372	CcSEcCtD
Gabapentin—Asthma—Varenicline—nicotine dependence	0.00247	0.00372	CcSEcCtD
Gabapentin—Angina pectoris—Varenicline—nicotine dependence	0.0024	0.00363	CcSEcCtD
Gabapentin—Bronchitis—Varenicline—nicotine dependence	0.00237	0.00358	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00232	0.0109	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CHRNA4—nicotine dependence	0.00228	0.0108	CbGpPWpGaD
Gabapentin—Pollakiuria—Varenicline—nicotine dependence	0.00228	0.00344	CcSEcCtD
Gabapentin—Erectile dysfunction—Varenicline—nicotine dependence	0.00227	0.00343	CcSEcCtD
Gabapentin—Photosensitivity reaction—Varenicline—nicotine dependence	0.00225	0.0034	CcSEcCtD
Gabapentin—Weight increased—Varenicline—nicotine dependence	0.00224	0.00339	CcSEcCtD
Gabapentin—Hyperglycaemia—Varenicline—nicotine dependence	0.00222	0.00336	CcSEcCtD
Gabapentin—Infestation NOS—Varenicline—nicotine dependence	0.0022	0.00332	CcSEcCtD
Gabapentin—Infestation—Varenicline—nicotine dependence	0.0022	0.00332	CcSEcCtD
Gabapentin—Depression—Varenicline—nicotine dependence	0.00219	0.00331	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00218	0.00329	CcSEcCtD
Gabapentin—Acute coronary syndrome—Varenicline—nicotine dependence	0.00217	0.00327	CcSEcCtD
Gabapentin—Myocardial infarction—Varenicline—nicotine dependence	0.00216	0.00325	CcSEcCtD
Gabapentin—Stomatitis—Varenicline—nicotine dependence	0.00214	0.00324	CcSEcCtD
Gabapentin—Conjunctivitis—Varenicline—nicotine dependence	0.00214	0.00323	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00209	0.00986	CbGpPWpGaD
Gabapentin—Hepatobiliary disease—Varenicline—nicotine dependence	0.00208	0.00314	CcSEcCtD
Gabapentin—Epistaxis—Varenicline—nicotine dependence	0.00207	0.00313	CcSEcCtD
Gabapentin—Sinusitis—Varenicline—nicotine dependence	0.00206	0.00311	CcSEcCtD
Gabapentin—Bradycardia—Varenicline—nicotine dependence	0.00201	0.00303	CcSEcCtD
Gabapentin—Hallucination—Varenicline—nicotine dependence	0.00196	0.00297	CcSEcCtD
Gabapentin—Hypoaesthesia—Varenicline—nicotine dependence	0.00196	0.00297	CcSEcCtD
Gabapentin—Urinary tract disorder—Varenicline—nicotine dependence	0.00195	0.00294	CcSEcCtD
Gabapentin—Oedema peripheral—Varenicline—nicotine dependence	0.00194	0.00294	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00194	0.00915	CbGpPWpGaD
Gabapentin—Connective tissue disorder—Varenicline—nicotine dependence	0.00194	0.00293	CcSEcCtD
Gabapentin—Urethral disorder—Varenicline—nicotine dependence	0.00194	0.00292	CcSEcCtD
Gabapentin—Visual impairment—Varenicline—nicotine dependence	0.0019	0.00287	CcSEcCtD
Gabapentin—Erythema multiforme—Varenicline—nicotine dependence	0.00187	0.00282	CcSEcCtD
Gabapentin—Eye disorder—Varenicline—nicotine dependence	0.00184	0.00279	CcSEcCtD
Gabapentin—Tinnitus—Varenicline—nicotine dependence	0.00184	0.00278	CcSEcCtD
Gabapentin—Cardiac disorder—Varenicline—nicotine dependence	0.00183	0.00277	CcSEcCtD
Gabapentin—Immune system disorder—Varenicline—nicotine dependence	0.00178	0.00269	CcSEcCtD
Gabapentin—Mediastinal disorder—Varenicline—nicotine dependence	0.00178	0.00269	CcSEcCtD
Gabapentin—Chills—Varenicline—nicotine dependence	0.00177	0.00267	CcSEcCtD
Gabapentin—Mental disorder—Varenicline—nicotine dependence	0.00173	0.00261	CcSEcCtD
Gabapentin—Malnutrition—Varenicline—nicotine dependence	0.00172	0.00259	CcSEcCtD
Gabapentin—Erythema—Varenicline—nicotine dependence	0.00172	0.00259	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—DRD2—nicotine dependence	0.00171	0.00808	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0017	0.008	CbGpPWpGaD
Gabapentin—Flatulence—Varenicline—nicotine dependence	0.00169	0.00256	CcSEcCtD
Gabapentin—Dysgeusia—Varenicline—nicotine dependence	0.00168	0.00254	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00166	0.00784	CbGpPWpGaD
Gabapentin—Back pain—Varenicline—nicotine dependence	0.00166	0.00251	CcSEcCtD
Gabapentin—Muscle spasms—Varenicline—nicotine dependence	0.00165	0.00249	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CYP2A7—nicotine dependence	0.00163	0.0077	CbGpPWpGaD
Gabapentin—Vision blurred—Varenicline—nicotine dependence	0.00162	0.00245	CcSEcCtD
Gabapentin—Tremor—Varenicline—nicotine dependence	0.00161	0.00243	CcSEcCtD
Gabapentin—Ill-defined disorder—Varenicline—nicotine dependence	0.00159	0.00241	CcSEcCtD
Gabapentin—Anaemia—Varenicline—nicotine dependence	0.00159	0.0024	CcSEcCtD
Gabapentin—Agitation—Varenicline—nicotine dependence	0.00158	0.00238	CcSEcCtD
Gabapentin—Angioedema—Varenicline—nicotine dependence	0.00157	0.00237	CcSEcCtD
Gabapentin—Malaise—Varenicline—nicotine dependence	0.00155	0.00234	CcSEcCtD
Gabapentin—Vertigo—Varenicline—nicotine dependence	0.00154	0.00233	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00154	0.00727	CbGpPWpGaD
Gabapentin—Syncope—Varenicline—nicotine dependence	0.00154	0.00233	CcSEcCtD
Gabapentin—Palpitations—Varenicline—nicotine dependence	0.00152	0.00229	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00151	0.00713	CbGpPWpGaD
Gabapentin—Loss of consciousness—Varenicline—nicotine dependence	0.00151	0.00228	CcSEcCtD
Gabapentin—Cough—Varenicline—nicotine dependence	0.0015	0.00226	CcSEcCtD
Gabapentin—Convulsion—Varenicline—nicotine dependence	0.00149	0.00225	CcSEcCtD
Gabapentin—Hypertension—Varenicline—nicotine dependence	0.00148	0.00224	CcSEcCtD
Gabapentin—Chest pain—Varenicline—nicotine dependence	0.00146	0.00221	CcSEcCtD
Gabapentin—Arthralgia—Varenicline—nicotine dependence	0.00146	0.00221	CcSEcCtD
Gabapentin—Myalgia—Varenicline—nicotine dependence	0.00146	0.00221	CcSEcCtD
Gabapentin—Anxiety—Varenicline—nicotine dependence	0.00146	0.0022	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00145	0.00219	CcSEcCtD
Gabapentin—Discomfort—Varenicline—nicotine dependence	0.00145	0.00218	CcSEcCtD
Gabapentin—Dry mouth—Varenicline—nicotine dependence	0.00143	0.00216	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0014	0.00662	CbGpPWpGaD
Gabapentin—Oedema—Varenicline—nicotine dependence	0.0014	0.00212	CcSEcCtD
Gabapentin—Infection—Varenicline—nicotine dependence	0.00139	0.0021	CcSEcCtD
Gabapentin—Shock—Varenicline—nicotine dependence	0.00138	0.00208	CcSEcCtD
Gabapentin—Nervous system disorder—Varenicline—nicotine dependence	0.00138	0.00208	CcSEcCtD
Gabapentin—Thrombocytopenia—Varenicline—nicotine dependence	0.00137	0.00207	CcSEcCtD
Gabapentin—Tachycardia—Varenicline—nicotine dependence	0.00137	0.00207	CcSEcCtD
Gabapentin—Skin disorder—Varenicline—nicotine dependence	0.00136	0.00206	CcSEcCtD
Gabapentin—Hyperhidrosis—Varenicline—nicotine dependence	0.00136	0.00205	CcSEcCtD
Gabapentin—Anorexia—Varenicline—nicotine dependence	0.00134	0.00202	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—FGD1—nicotine dependence	0.00133	0.00628	CbGpPWpGaD
Gabapentin—Hypotension—Varenicline—nicotine dependence	0.00131	0.00198	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00128	0.00193	CcSEcCtD
Gabapentin—Insomnia—Varenicline—nicotine dependence	0.00127	0.00192	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—OPRM1—nicotine dependence	0.00127	0.00597	CbGpPWpGaD
Gabapentin—Dyspnoea—Varenicline—nicotine dependence	0.00125	0.00189	CcSEcCtD
Gabapentin—Somnolence—Varenicline—nicotine dependence	0.00125	0.00188	CcSEcCtD
Gabapentin—Dyspepsia—Varenicline—nicotine dependence	0.00123	0.00186	CcSEcCtD
Gabapentin—Decreased appetite—Varenicline—nicotine dependence	0.00122	0.00184	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00121	0.00183	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—FGD1—nicotine dependence	0.00121	0.0057	CbGpPWpGaD
Gabapentin—Fatigue—Varenicline—nicotine dependence	0.00121	0.00183	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0012	0.00567	CbGpPWpGaD
Gabapentin—Constipation—Varenicline—nicotine dependence	0.0012	0.00181	CcSEcCtD
Gabapentin—Pain—Varenicline—nicotine dependence	0.0012	0.00181	CcSEcCtD
Gabapentin—Feeling abnormal—Varenicline—nicotine dependence	0.00116	0.00174	CcSEcCtD
Gabapentin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00115	0.00173	CcSEcCtD
Gabapentin—Urticaria—Varenicline—nicotine dependence	0.00111	0.00168	CcSEcCtD
Gabapentin—Abdominal pain—Varenicline—nicotine dependence	0.00111	0.00167	CcSEcCtD
Gabapentin—Body temperature increased—Varenicline—nicotine dependence	0.00111	0.00167	CcSEcCtD
Gabapentin—Hypersensitivity—Varenicline—nicotine dependence	0.00103	0.00156	CcSEcCtD
Gabapentin—Asthenia—Varenicline—nicotine dependence	0.00101	0.00152	CcSEcCtD
Gabapentin—Pruritus—Varenicline—nicotine dependence	0.000992	0.0015	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP2A7—nicotine dependence	0.00099	0.00466	CbGpPWpGaD
Gabapentin—Diarrhoea—Varenicline—nicotine dependence	0.00096	0.00145	CcSEcCtD
Gabapentin—Dizziness—Varenicline—nicotine dependence	0.000927	0.0014	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—DRD2—nicotine dependence	0.000916	0.00432	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TAS2R16—nicotine dependence	0.000911	0.00429	CbGpPWpGaD
Gabapentin—Vomiting—Varenicline—nicotine dependence	0.000892	0.00135	CcSEcCtD
Gabapentin—Rash—Varenicline—nicotine dependence	0.000884	0.00134	CcSEcCtD
Gabapentin—Dermatitis—Varenicline—nicotine dependence	0.000883	0.00133	CcSEcCtD
Gabapentin—Headache—Varenicline—nicotine dependence	0.000879	0.00133	CcSEcCtD
Gabapentin—Nausea—Varenicline—nicotine dependence	0.000833	0.00126	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000716	0.00337	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGD1—nicotine dependence	0.000715	0.00337	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—OPRM1—nicotine dependence	0.00065	0.00306	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKR1B10—nicotine dependence	0.000632	0.00298	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—DRD2—nicotine dependence	0.000518	0.00244	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—DRD2—nicotine dependence	0.00047	0.00222	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—WASF2—nicotine dependence	0.000445	0.0021	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—WASF1—nicotine dependence	0.000427	0.00201	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—OPRM1—nicotine dependence	0.000384	0.00181	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DRD2—nicotine dependence	0.000278	0.00131	CbGpPWpGaD
